High quality raw material for IVD manufacturing industry

Recombinant antigen EBNA1 for Epstein-barr virus

Epstein-barr virus

EBNA1 has a predominant role in the maintenance of latent EBV infections and is expressed in all EBV infections and all EBV-associated malignant tissues. It contains a Gly-Ala repeated domain flanked by two unique regions. The central , C-terminus and N-terminus regions have been described as potentially antigenic.

View more information about Epstein-Barr virus infection.

REFERENCES
RAG0007 WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA
RAG0047 WB, DB, Indirect ELISA, positive control in direct ELISA
GENE
BKRF1
DESCRIPTION
Late nuclear antigen
PURITY
>95% in a SDS-PAGE
SHIPPING AND STORAGE CONDITIONS
Proteins will be shipped on dry ice or ice pack. Upon arrival they should be stored at -20ºC to -80ºC. Avoid multiple freeze/thaw cycles
STABILITY
The protein will remain stable for four years if stored frozen
SPECIFICITY
The protein is immunoreactive against seropositive individuals to Epstein-Barr virus infection
IVD
Serodiagnosis of infectious mononucleosis associated to EBV and primary acute infections in immunocompromised individuals
SATISFACTION GUARANTEE
83% success rate in evaluations of recombinant antigen EBNA1 (RAG0007) for the development of a diagnostic assay
100% success rate in evaluations of recombinant antigen EBNA1 (RAG0047) for the development of a diagnostic assay
EVALUATION
RELATED PRODUCTS

FOR RESEARCH USE ONLY

RETURN TO RECOMBINANT ANTIGENS